reproductiverights.org
Sep 10, 2026, 13:29
Center for Reproductive Rights’ New Medication Abortion Defense Portal – ASRM
American Society for Reproductive Medicine (ASRM) shared on LinkedIn։
“Ahead of today’s oral arguments in LA v. FDA, ASRM reasserts that using mifepristone for miscarriage care and medication abortion is safe, effective, and supported by decades of clinical evidence. Restricting access makes care more expensive and out of reach, harming patients and providers alike.
Visit the Center for Reproductive Rights’ new Medication Abortion Defense Portal for more.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Sep 10, 2026, 16:35Devyanshi Dixit: What If the Brain and Reproductive System Are Having a Conversation We’re Still Learning to Hear?
-
Sep 10, 2026, 16:30Save the Date for the ISUOG 2027 World Congress
-
Sep 10, 2026, 16:27Sean Lauber: Which Embryo Culture Medium Offers the Best Chance of a Live Birth?
-
Sep 10, 2026, 16:18New Human Reproduction Press Release on Paracetamol Use During Pregnancy – ESHRE
-
Sep 10, 2026, 16:14Devyanshi Dixit: Menstrual Health – The Vital Sign We Still Don’t Measure Properly
-
Sep 10, 2026, 16:13Margaret Cali: Everybody Told Me to Relax, but Nobody Told Me What to Do With the Fear…
-
Sep 10, 2026, 16:09Clare Mansfield: The Deeply Personal Question Flowering Fertility Started With
-
Sep 10, 2026, 16:07Carmen Mair: Stop Buying Fertility Supplements Before You Know What You’re Actually Trying to Correct
-
Sep 10, 2026, 16:03Devyanshi Dixit: Can We Predict Who Will Have Severe Menopause Symptoms?